In this article
The short answer
The EU placing-on-the-market date for the expanded fragrance allergen list passed on 31 July 2026. Old-label products can stay on EU and Northern Ireland shelves until 31 July 2028 only if they were first supplied into the chain before that date, so you need dispatch records to prove it. Audit each SKU: is the label right, does the PIF hold the dated breakdown and your calculation, and does any citral or benzyl salicylate exceed the new limits that apply from 1 January 2027.
Key takeaways
- The 31 July 2026 date has passed. Since then, EU and Northern Ireland products must carry the expanded allergen names.
- Old-label stock can be sold until 31 July 2028 only if it was placed on the market before 31 July 2026. Stock still in your own warehouse on that date was not.
- Prove placing dates with batch codes, invoices and dispatch notes that link together. If a batch cannot be tied to a dispatch, treat it as non-compliant.
- A right label with no dated breakdown and calculation in the PIF is still a gap.
- Regulation (EU) 2026/909 sets product-type maximums for citral and benzyl salicylate from 1 January 2027. A citral-rich deodorant can need reformulating, not just relabelling.
- Label changes alone do not trigger the Article 13(7) notification update duty, but formula or frame formulation changes can.
- Great Britain still uses the original allergen entries and has no citral maximums, as checked on 18 November 2026.
Take a body care brand with twelve lines. Nine have new artwork. The other three are still in the old packs, and around 1,400 of those units sit in a pallet store in Rotterdam. The founder wants to know whether she can keep shipping them to her German stockists until 2028. The honest answer is "it depends on what happened to those units before 31 July 2026", and in our experience that is exactly the fact nobody wrote down.
That is where most brands are now. The placing-on-the-market date for the expanded EU fragrance allergen list has passed, so the work is no longer about planning artwork. It is about proving, product by product, that what you sell today is either compliant or legitimately covered by the sell-through window. This checklist is built for that audit. If you need the background on what changed, our guide to the expanded EU fragrance allergen list and its 2026 and 2028 deadlines covers it, what fragrance allergens are explains the list itself, and how to label fragrance allergens deals with placing the names on the pack. Here we stay with the checking.
One word on the number. You will see this called the 82 fragrance allergen labelling deadline almost everywhere. That figure is the original 26 plus the 56 additions, but two of the 26 had already been banned, and the amended Annex III ends up with 81 entries carrying the labelling condition. It makes no difference to your audit. What matters is that your supplier's breakdown covers every one of them.
Where things stand on 18 November 2026
Regulation (EU) 2023/1545 gave every new entry the same transitional wording: products that do not comply may be placed on the Union market until 31 July 2026 and made available until 31 July 2028. The European Commission's fragrance allergen labelling page puts it the same way. So the first door has closed and the second is open for another twenty months.
There is a newer date to add to the same calendar. Regulation (EU) 2026/909 replaces Annex III entry 70, citral, and entry 75, benzyl salicylate. Both stay declarable above the usual thresholds, but both now also get maximum concentrations that depend on the product type. That is a formulation limit, not a labelling rule, and it lands on many of the same fragranced products, so it belongs in the same audit.
| Date | What happens | Where it comes from |
|---|---|---|
| 31 July 2026 (passed) | Products that do not meet the expanded allergen labelling can no longer be placed on the EU market | Regulation (EU) 2023/1545, Annex III transitional note |
| 1 January 2027 | Products containing citral or benzyl salicylate above the new product-type maximums can no longer be placed on the EU market | Regulation (EU) 2026/909 |
| 1 July 2028 | Non-compliant citral and benzyl salicylate products already on the market must come off sale | Regulation (EU) 2026/909 |
| 31 July 2028 | Old-label stock placed on the market before 31 July 2026 can no longer be made available, so it must be off every EU and Northern Ireland shelf | Regulation (EU) 2023/1545 |
| 1 August 2028 | Sell-through ends for the geranial and neral lines of the citral entry | Regulation (EU) 2026/909 |
The thresholds themselves did not move: a declarable allergen must be named above 0.001% in a leave-on product and above 0.01% in a rinse-off product, measured in the finished product.
Step 1: build a register of every scented SKU
Do this before you look at a single label. A spreadsheet is fine. One row per SKU, and by SKU we mean every shade, scent and size that has its own artwork, because a 50 ml and a 200 ml of the same lotion often have different print files and different stock positions.
The columns we use are: product name and SKU code, product type (leave-on or rinse-off, plus the 2026/909 category), markets sold in, fragrance compound or essential oils used, fragrance dose in the formula, date of the supplier breakdown you hold, current artwork version and its first print date, old-label units on hand and where they physically are, and the bucket the line ends up in. Add a column for citral and one for benzyl salicylate, because you will need both later.
Gaps in this sheet are findings in their own right. If nobody can say what fragrance dose a product uses, nobody can have calculated its declarable allergens either.
Step 2: put every SKU in one of four buckets
Once the register is filled, each line falls into one of these. Be strict. A line is only in bucket A if both the pack and the file are right.
| Bucket | What you find | What to do |
|---|---|---|
| A. Done | New label in use, file holds the expanded-list breakdown and your calculation | Spot-check one batch against the artwork and close the line |
| B. Label fixed, file not | Correct names on the pack, but the PIF still holds the old breakdown or no arithmetic | Rebuild the evidence now. This is the gap an inspection finds first |
| C. Old label, placed before 31 July 2026 | Units first supplied into the chain before the date, with paperwork to prove it | Keep selling until 31 July 2028 at the latest, file the proof, plan the run-down |
| D. Old label, not placed in time | Units still in your own stock on 31 July 2026, or made after it, still in old packs | Do not ship them to EU or Northern Ireland customers. Relabel, divert to a market where the pack is compliant, or write them off |
Bucket B is the one that surprises people. The artwork was updated in a rush in spring, the printer delivered, and everyone moved on. But the label was changed on the strength of an email from the fragrance house, and the dated breakdown and the calculation never made it into the Product Information File. The pack is right and the file cannot show why. Bucket D is the expensive one, and it is usually smaller than people fear once the paperwork is checked.
Step 3: prove when the old stock was placed on the market
The sell-through window only covers products placed on the market before 31 July 2026. Placing on the market means the first making available of the product, and making available means any supply for distribution, consumption or use in the course of a commercial activity, paid or free. Those definitions sit in Article 2 of the Cosmetics Regulation. In practice the question for any carton of old-label stock is simple: had that stock already been supplied into the EU chain before the date, or was it still sitting with you?
Units that had already gone to a distributor or retailer before 31 July 2026 can generally keep moving until 31 July 2028. Units that were still in your own warehouse, unsold to anyone, had not been placed on the market, so the old wording cannot be used for them now. Go back to the Rotterdam pallet. Suppose the batch codes match dispatch notes showing 900 of those units were invoiced to a distributor in June and simply never collected, while the other 500 had never been supplied to anyone. The first 900 have a good case for the sell-through window to 31 July 2028. The 500 are a relabelling job.
The evidence that holds up is ordinary commercial paperwork that links together:
- Batch codes on the units, matched to production records. Our article on batch codes and net quantity on cosmetic labels explains why that code is your traceability anchor.
- Invoices, delivery notes or proof of dispatch dated before 31 July 2026, showing those batches going to a named customer.
- A stock report from around the date showing what was still on hand, so you can show what was not supplied as well as what was.
- For stock held by a third-party logistics provider or a marketplace fulfilment service, the contract and the transfer records. Whether a transfer counts as supply depends on who owns the goods and who you transferred them to, so take advice on those before relying on them.
File the evidence against each SKU. If you cannot tie a batch to a dispatch before the date, treat it as bucket D.
Step 4: assemble the PIF evidence pack
The Product Information File has to support the product as it is now sold, and the label is only the visible end of it. For each SKU in buckets A and B, these are the documents we expect to find. Our Product Information File template and checklist shows where each one fits in the wider file.
| Document | What it proves | Watch for |
|---|---|---|
| Supplier allergen breakdown for each compound, dated, against the expanded list | Which declarable substances are present, as a percentage of the compound | Breakdowns that list only the original substances. Silence on the additions is not a zero |
| The superseded breakdown | What you knew, and when | Keep it. Replacing it destroys the history |
| Finished-product calculation sheet | Which names must appear and why the others do not | Leave-on or rinse-off threshold recorded, plus every substance that fell below the line |
| Citral and benzyl salicylate check | That each product is under the 2026/909 maximum for its product type | The product category used, since the limits differ sharply between types |
| Safety assessor's note or CPSR addendum | That the assessor saw the new information and decided whether the assessment changes | A decision either way, signed and dated |
| Artwork version and date of first use | Which label applies to which batches | Every component with an ingredient list: carton, tube, leaflet |
| Placing-on-the-market evidence for old-label stock | That bucket C units really were first supplied before 31 July 2026 | Dispatch notes, invoices and batch codes that link up |
| Notification record | That the CPNP or SCPN entry was checked and updated where needed | A short note when no update was legally required |
| Market decision and distributor letters | Which label goes to which market, and that the chain was told the dates | Dated copies, not just the sent folder |
Two of these deserve a comment. The calculation sheet is your document, not your supplier's. The breakdown gives percentages of the compound; only you know how much compound is in the product, so the multiplication and the declare or do not declare decision are yours to record, including the substances that come out below the line. And the assessor's note matters even when nothing changes. Our guide to keeping a CPSR up to date sets out when new information needs a revised assessment, but the decision is the assessor's to make and it should be on paper with a date.
Step 5: check citral and benzyl salicylate before 1 January 2027
While the supplier breakdowns are open on your desk, read two lines off them: citral and benzyl salicylate. From 1 January 2027 a product above the new maximum for its type cannot be placed on the EU market. Products already on the market have until 1 July 2028, except that the geranial and neral lines of the citral entry run to 1 August 2028. If you are not sure which line your raw material falls under, plan to the earlier date.
| Product type (2026/909 wording, shortened) | Maximum citral in the finished product |
|---|---|
| Deodorants and antiperspirants | 0.032% |
| Leave-on products for the anogenital area (baby and intimate wipes) | 0.063% |
| Lip make-up, lipstick, lip salves | 0.11% |
| Leave-on skin products and nail products (not covered by another line) | 0.15% |
| Oral products | 0.35% |
| Fragrance products (hydroalcoholic or not, spray or not) | 0.6% |
| Eye products, face make-up and make-up remover | 0.65% |
| Hair leave-on products; skin and hair rinse-off products | 1.2% |
The arithmetic is the same as for allergen declarations. Take a natural deodorant with 0.5% lemongrass oil. Lemongrass is rich in citral, often well over half the oil, so if your batch analysis says 75% citral, the finished product contains about 0.375%. The deodorant limit is 0.032%. That product needs reformulating, not relabelling. A body lotion with 1% of a fragrance compound containing 4% citral comes out at 0.04%, comfortably under the 0.15% leave-on skin limit. Same ingredient, very different outcomes, which is why the product type column in your register matters.
Benzyl salicylate gets its own set of product-type maximums under the same regulation. Check it the same way. Both entries remain declarable, and citral, geranial and neral are declared under the single name Citral when above the thresholds. For the wider picture of how restricted entries work, see our explainer on restricted ingredients and Annex III, and note that an IFRA certificate is an industry standard, not proof against the legal limits.
Step 6: decide what the notification needs
This is where we see brands either over-work or under-work. Under Article 13(7), the responsible person must update the notification without delay when information under paragraphs 1, 3 or 4 changes. Those cover things like the product name and category, the responsible person's details, nanomaterials, CMR substances and the frame formulation. The original labelling and the pack photograph sit in paragraph 2, which is not on that list.
So a pure label change does not, on the wording, trigger the update duty. Many responsible persons upload the new artwork anyway, so that what authorities and poison centres see matches the pack, and that is a sensible habit. If the fragrance compound or dose changed, or a citral reformulation is coming, look again at the frame formulation, because that is in paragraph 1. Either way, write a one-line note in the file saying what you checked and what you did. Our article on notifying cosmetic variants covers how one change can ripple across a family of notified shades or scents.
Step 7: settle the Great Britain and Northern Ireland position
Northern Ireland follows EU cosmetics law under the Windsor Framework, so the EU dates and the expanded list apply to products sold there, as OPSS's Northern Ireland guidance explains. Our guide to CPNP notification for Northern Ireland covers the practical side.
Great Britain is different. The GB version of Annex III on legislation.gov.uk, checked on 18 November 2026, still carries only the original allergen entries, and its citral entry still has the labelling condition with no product-type maximums. That makes the market column in your register important. A bucket D unit in an old pack may still be sellable in Great Britain if the pack meets every other GB requirement, including a UK Responsible Person address. Many brands run one artwork to the longer EU list for both markets, which is fine as long as the extra names are genuinely present and the decision is recorded in the file.
Step 8: write to the chain and set your run-down plan
Retailers and distributors holding bucket C stock need to know the 31 July 2028 date, and a stockist with a slow-moving line needs to hear it now rather than in May 2028. Send a short dated letter or email per customer: which SKUs, which batches, the last date they can be sold, and who to contact. Keep the copies in the file.
Then work backwards from your slowest line. If a scent sells forty units a month in the EU and there are 1,200 old-label units in the chain, that stock runs out with time to spare. If it sells ten, it will not, and a stickering or withdrawal plan should be in the calendar now. Our guide to product recall and withdrawal explains how to run a controlled withdrawal if it comes to that. Where you sticker, use a durable label carrying the full corrected ingredient list on every component that shows one, and record the batches it went on.
Done properly, the audit leaves you with something useful beyond this deadline: a register that tells you, for every product, which fragrance it uses, at what dose, and with what documents. The next time Annex III changes, and the citral and benzyl salicylate amendments show it will, the work takes days rather than months.
Want a second pair of eyes on your SKU register?
Send us your product list with fragrance doses, the supplier breakdowns you hold and where your old-label stock sits. We sort every line into its bucket, recalculate the declarable allergens and the citral and benzyl salicylate levels, and tell you which files, labels and notifications still need work.
Related reading
- Fragrance allergen labelling: the expanded EU list, 2026 and 2028 deadlines and Great Britain rules
- What are fragrance allergens? Why the list went from 26 to more than 80
- How to label fragrance allergens
- Cosmetic PIF template and checklist
- CPSR renewal and updates
- CPSR for perfumes: a safety guide
- All regulatory compliance articles
Myths we hear
- We have until 2028. Only for stock placed on the market before 31 July 2026. Anything first supplied after that date must already carry the expanded list.
- The new labels are printed, so we are compliant. Not until the PIF holds the dated supplier breakdown, your finished-product calculation and the assessor's view. The file is what an inspector reads.
- Stock in our warehouse counts as on the market. Placing on the market is the first supply into the chain. Units you had not supplied to anyone by 31 July 2026 do not get the sell-through window.
- Citral only matters for labelling. From 1 January 2027 it also has maximum concentrations by product type, as low as 0.032% in deodorants.
- Every label change means a new CPNP notification. Article 13(7) lists the information whose change triggers an update, and the label photograph is not on it. A formula change can be.
What to do this week
- Build a register of every scented SKU with fragrance dose, markets, artwork version and old-label stock by location.
- Sort each SKU into bucket A, B, C or D and be strict about it.
- For bucket C, file batch codes, invoices and dispatch notes dated before 31 July 2026.
- Stop shipping bucket D units to EU and Northern Ireland customers and decide between relabelling, diverting and writing off.
- Put the dated breakdown, superseded breakdown, calculation sheet and assessor's note into each PIF.
- Check citral and benzyl salicylate against the 2026/909 limits for each product type before 1 January 2027.
- Record what you checked on each CPNP or SCPN notification and update the frame formulation where the formula changed.
- Write to every stockist holding old-label stock with the batches and the last sale date.
Frequently asked questions
Can I still sell products with the old fragrance allergen labels?
In the EU and Northern Ireland, only if those units were placed on the market before 31 July 2026, and only until 31 July 2028. Anything first supplied after 31 July 2026 must already carry the expanded allergen names.
Does stock sitting in my own warehouse count as placed on the market?
Generally not. Placing on the market is the first making available, which means supplying the product to someone in the course of business. Units you still held and had not supplied to anyone by 31 July 2026 do not benefit from the sell-through window.
How do I prove old stock was placed on the market in time?
Link batch codes on the units to production records and to invoices or dispatch notes dated before 31 July 2026. A stock report from around the date helps show what was still on hand. File the proof against each SKU.
Is it 82 or 81 fragrance allergens?
82 is the original 26 plus the 56 additions. Two of the 26 were banned before the change, and the amended Annex III has 81 entries carrying the labelling condition. Your supplier breakdown needs to cover all of them either way.
What should the PIF contain for the allergen change?
The dated supplier breakdown against the expanded list, the superseded version, your finished-product calculation including substances below the threshold, the assessor's note on whether the safety assessment changes, and the artwork version with its first date of use.
What changes for citral on 1 January 2027?
Regulation (EU) 2026/909 sets maximum concentrations by product type, for example 0.032% in deodorants, 0.15% in most leave-on skin products and 0.6% in fragrance products. Non-compliant products cannot be placed on the EU market from 1 January 2027.
Do I need to update my CPNP notification after a label change?
Article 13(7) requires an update when information in paragraphs 1, 3 or 4 changes. The label and pack photograph are in paragraph 2, so a pure label change does not trigger it, though many responsible persons upload new artwork anyway. A formula change can affect the frame formulation.
Does the deadline apply in Great Britain?
No. As checked on 18 November 2026, the GB version of Annex III still carries only the original allergen entries and no citral maximums. Northern Ireland follows the EU rules and dates.
Official sources and legislation
- European Commission: Fragrance allergens labelling (Regulation (EU) 2023/1545, thresholds and the 31 July 2026 and 31 July 2028 dates)
- Regulation (EU) 2026/909: Annex text as transmitted to the Council (doc. 5405/26 ADD 1), citral and benzyl salicylate entries and transitional dates
- Regulation (EC) No 1223/2009, Article 2 (definitions), EU text as at 31 January 2020, legislation.gov.uk
- Regulation (EC) No 1223/2009, Article 11 (Product Information File), legislation.gov.uk
- Regulation (EC) No 1223/2009, Article 13 (notification), EU text as at 31 January 2020, legislation.gov.uk
- Regulation (EC) No 1223/2009, Annex III, as it applies in Great Britain, legislation.gov.uk
- OPSS: Regulation 1223/2009 and the Cosmetic Products Enforcement Regulations 2013, Great Britain guidance
- OPSS: Regulation 1223/2009 and the Cosmetic Products Enforcement Regulations 2013, Northern Ireland guidance
- AEMPS (Spain): Fragrance allergens subject to mandatory declaration, by Annex III entry
- European Commission: CosIng database of cosmetic ingredients
Join the conversation